Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy
Completed · Phase 3 · Has a placebo group
Conditions studied: Hepatitis C
In brief
The primary objectives of this study are to evaluate the safety and efficacy of treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) in adults with chronic hepatitis C virus (HCV) infection who have previously received treatment with direct-acting antiviral therapy. Participants randomized to placebo may be eligible for deferred treatment with active SOF/VEL/VOX.
Key facts
- Study ID
- NCT02607735
- Run by
- Gilead Sciences
- People needed
- 416
- Starts
- 2015-11-11
- Expected to finish
- 2017-06-21
- Last updated by the study team
- 2019-03-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Los Angeles, California, United States
- Study site — Palo Alto, California, United States
- Study site — Pasadena, California, United States
- Study site — Rialto, California, United States
- Study site — San Diego, California, United States
- Study site — San Francisco, California, United States
- Study site — Aurora, Colorado, United States
- Study site — Englewood, Colorado, United States
- Study site — Washington D.C., District of Columbia, United States
- Study site — Gainesville, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Orlando, Florida, United States
- Study site — Wellington, Florida, United States
- Study site — Atlanta, Georgia, United States
- Study site — Marietta, Georgia, United States
- Study site — Chicago, Illinois, United States
- Study site — Indianapolis, Indiana, United States
- Study site — Baltimore, Maryland, United States
- Study site — Catonsville, Maryland, United States
- Study site — Boston, Massachusetts, United States
- Study site — Ann Arbor, Michigan, United States
- Study site — Detroit, Michigan, United States
- Study site — Kansas City, Missouri, United States
- Study site — St Louis, Missouri, United States
- Study site — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.